G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases.
暂无分享,去创建一个
Bernd Hertenstein | Arnold Ganser | A. Ganser | J. Buer | Wenji Piao | W. Hansen | B. Hertenstein | Wenji Piao | Jan Buer | A. Franzke | Anke Franzke | J. Lauber | Jörg Lauber | Wiebke Hansen | Patricia Gatzlaff | Christian Könecke | Angela Schmitt-Thomsen | C. Könecke | Angela Schmitt-Thomsen | P. Gatzlaff | Patricia Gatzlaff
[1] Y. Wu,et al. Identification of a costimulatory molecule rapidly induced by CD40L as CD44H , 1996, The Journal of experimental medicine.
[2] Richard A Flavell,et al. The Transcription Factor GATA-3 Is Necessary and Sufficient for Th2 Cytokine Gene Expression in CD4 T Cells , 1997, Cell.
[3] G. Peltz,et al. GATA-3-dependent enhancer activity in IL-4 gene regulation. , 1998, Journal of immunology.
[4] W. Ouyang,et al. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. , 1998, Immunity.
[5] M. Mielcarek,et al. Phenotype and engraftment potential of cytokine‐mobilized peripheral blood mononuclear cells , 1997, Current opinion in hematology.
[6] J. Buer,et al. Fingerprints of anergic T cells , 2001, Current Biology.
[7] K. Sullivan,et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. , 1997, Blood.
[8] L. Hennighausen,et al. Stimulation of Stat5 by granulocyte colony-stimulating factor (G-CSF) is modulated by two distinct cytoplasmic regions of the G-CSF receptor. , 1998, Journal of immunology.
[9] G. Hill,et al. G-CSF modulates cytokine profile of dendritic cells and decreases acute graft-versus-host disease through effects on the donor rather than the recipient. , 2000, Transplantation.
[10] M. Álvarez-Mon,et al. Granulocyte colony-stimulating factor (G-CSF) transiently suppresses mitogen-stimulated T-cell proliferative response , 1999, British Journal of Cancer.
[11] J. Buer,et al. Interleukin 10 Secretion and Impaired Effector Function of Major Histocompatibility Complex Class II–restricted T Cells Anergized In Vivo , 1998, The Journal of experimental medicine.
[12] C. Horvath,et al. Interferon regulatory factor subcellular localization is determined by a bipartite nuclear localization signal in the DNA-binding domain and interaction with cytoplasmic retention factors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[13] P. Boquet,et al. Functional analysis of four tetraspans, CD9, CD53, CD81, and CD82, suggests a common role in costimulation, cell adhesion, and migration: only CD9 upregulates HB-EGF activity. , 1997, Cellular immunology.
[14] J. Ferrara,et al. Long-term engraftment, graft-vs.-host disease, and immunologic reconstitution after experimental transplantation of allogeneic peripheral blood cells from G-CSF-treated donors. , 1996, Biology of Blood and Marrow Transplantation.
[15] K. Campbell,et al. CD5 signal transduction: positive or negative modulation of antigen receptor signaling. , 2000, Critical reviews in immunology.
[16] S. Strober,et al. Granulocyte colony-stimulating factor reduces the capacity of blood mononuclear cells to induce graft-versus-host disease: impact on blood progenitor cell transplantation. , 1997, Blood.
[17] M. Mielcarek,et al. Suppression of alloantigen-induced T-cell proliferation by CD14+ cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. , 1997, Blood.
[18] M. Koehler,et al. Cytokine-mobilized allogeneic peripheral blood stem cell transplants in children result in rapid engraftment and a high incidence of chronic GVHD , 2000, Bone Marrow Transplantation.
[19] T. Hartung,et al. Human monocytes express functional receptors for granulocyte colony-stimulating factor that mediate suppression of monokines and interferon-gamma. , 2000, Blood.
[20] M. Mielcarek,et al. Production of interleukin-10 by granulocyte colony-stimulating factor-mobilized blood products: a mechanism for monocyte-mediated suppression of T-cell proliferation. , 1998, Blood.
[21] T. Hartung,et al. Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. , 1995, Blood.
[22] S. Heimfeld,et al. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. , 2000, Blood.
[23] N. Young,et al. Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo. , 2000, Blood.
[24] A Radbruch,et al. Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment. , 2000, Immunity.
[25] Jinhua Lu,et al. Blocking L‐selectin and α4‐integrin changes donor cell homing pattern and ameliorates murine acute graft versus host disease , 2001, European journal of immunology.
[26] A. O’Garra,et al. Cutting Edge: Chromatin Remodeling at the IL-4/IL-13 Intergenic Regulatory Region for Th2-Specific Cytokine Gene Cluster1 , 2000, The Journal of Immunology.
[27] J. Ferrara,et al. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. , 1995, Blood.
[28] T. Taniguchi,et al. Essential and non‐redundant roles of p48 (ISGF3γ) and IRF‐1 in both type I and type II interferon responses, as revealed by gene targeting studies , 1996, Genes to cells : devoted to molecular & cellular mechanisms.
[29] J. Buer,et al. Monitoring gene expression of TNFR family members by β‐cells during development of autoimmune diabetes , 2000, European journal of immunology.
[30] N. Hogg,et al. Lymphocyte Migration in Lymphocyte Function-associated Antigen (LFA)-1–deficient Mice , 1999, The Journal of experimental medicine.